Comparative analysis reveals how HistoQC and PathProfiler enhance artefact detection in prostate cancer, indicating improved diagnostic methods.
HistoQC and PathProfiler reliably assess WSI quality in prostate cancer. PathProfiler offers efficiency for clinical use, while HistoQC provides adaptable scoring via machine learning. Together, they can enhance diagnostic accuracy and support integration of AI in digital pathology workflows.
No takes yet. Share an insight, caveat, or question.
Ravanelli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: